AbbVie Inc. is 199.7x more valuable than Zai Lab Ltd by market capitalization ($399.47 B vs $2.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZLAB | ABBV |
|---|---|---|
| Market cap | $2.00 B | $399.47 B |
| US-listed rank | #2098 | #28 |
| Revenue (latest FY) | $457.18M | $61.16B |
| Net income (latest FY) | -$175.50M | $4.23B |
| Net margin | -38.4% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 700 | 1,008 |
AbbVie Inc. is 199.7x more valuable than Zai Lab Ltd by market capitalization ($399.47 B vs $2.00 B).
In their latest fiscal years, Zai Lab Ltd reported $457.18M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Zai Lab Ltd and AbbVie Inc., or browse the full rankings.